StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$6.24−0.07 (-1.11%)

Close on Nov 12, 2026Market cap $42.32MP/E –Yield –

Instil Bio statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 12, 2026 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$42.79M
$289.51M
Enterprise Value
$37.25M
$155.84M
PB Ratio
0.40
2.13
P/TBV Ratio
0.40
2.38

Share statisticsIndustry

Shares Change (YoY)
3.60%
10.9%
Shares Change (QoQ)
0.00%
0.48%
Shares Held by Institutions
29.5%
56.4%

Short sellingIndustry

Short Interest
181,228
–
Short Interest Change
6.31%
-0.80%
Short % of Shares Outstanding
2.67%
6.30%
Days to Cover
2.28
5.15

Stock price statisticsIndustry

52-Week High
$16.00
–
52-Week Low
$5.56
–
20-Day Moving Average
$6.30
–
50-Day Moving Average
$6.79
–
200-Day Moving Average
$7.66
–
Average True Range (14)
$0.43
–
Price Change (1 Week)
-9.73%
-0.33%
Price Change (1 Month)
2.10%
-0.31%
Price Change (3 Months)
-13.2%
-17.1%
Price Change (6 Months)
-21.3%
-20.1%
Price Change (YTD)
-42.6%
-20.1%
Price Change (1 Year)
-57.4%
-19.3%
Price Change (3 Years)
-12.4%
-22.2%
Price Change (5 Years)
-98.5%
-76.4%
Average Volume (10 Days)
52,596
–
Average Volume (20 Days)
68,383
–
Average Volume (90 Days)
25,745
–
Relative Volume
2.11
0.73
Relative Strength Index (14)
45.0
47.6
Volatility (1 Year)
67.4%
80.2%
Beta (5 Years)
2.89
1.08

Returns on capitalIndustry

Return on Equity (ROE)
-25.3%
-51.3%
Return on Assets (ROA)
-14.1%
-40.7%
Return on Invested Capital (ROIC)
-26.0%
-32.9%
Return on Capital Employed (ROCE)
-19.1%
-38.1%

Financial positionIndustry

Current Ratio
21.67
3.30
Quick Ratio
1.68
2.40
Interest Coverage
-5.92
-6.35

EfficiencyIndustry

Profits Per Employee
-$1.78M
-$683.67K
Employee Count
17
75
WACC
17.4%
10.1%

Income statement (TTM)Industry

Operating Income
-$37.17M
-$20.99M
Net Income
-$30.28M
-$21.61M
EBITDA
-$36.89M
-$16.85M
EPS (Diluted)
-$4.47
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$5.54M
$16.56M
Net Cash Per Share
$0.82
$0.71
Equity (Book Value)
$107.38M
$52.23M
Book Value Per Share
$15.83
$1.50
Tangible Book Value
$107.38M
$26.10M
Working Capital
$68.30M
$78.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$23.61M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-70.8%
-20.1%

Taxes and interestIndustry

Interest Expense
$6.28M
$2.98M

Scores and fair valueIndustry

Altman Z-Score
-5.13
0.31
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTILS&P 500DifferenceTIL per yearS&P 500 per year
1 month-5.2%-2.7%−2.5 pts
3 months-16.6%-1.7%−14.8 pts
Year to date-43.3%+11.9%−55.2 pts
1 year-58.4%+12.0%−70.4 pts
3 years-10.9%+78.2%−89.0 pts-3.8%+21.2%
5 years-98.5%+73.2%−171.7 pts-56.8%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M TIL shares were sold short on Oct 30, 2026, up 6.3% from the previous report. At recent volumes it would take 2.3 days to buy them back. Over the last 20 sessions, 34.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026181,228+6.3%79,3632.3
Oct 15, 2026170,479+7.2%25,2436.8
Sep 30, 2026159,044-1.7%17,0869.3
Sep 15, 2026161,870+3.2%12,32913.1
Aug 31, 2026156,830-11.1%6,85122.9
Aug 14, 2026176,320-6.8%8,20021.5
Jul 31, 2026189,165-7.2%10,63317.8
Jul 15, 2026203,828-13.2%13,19815.4
Jun 30, 2026234,769+0.4%22,02310.7
Jun 15, 2026233,731+0.4%13,17517.7
May 29, 2026232,840+0.6%37,2086.3
May 15, 2026231,366-11.2%30,1567.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?